Device Trial Radar · NCT06753110
A Multicenter, Multinational, Cohort Long-term Post-market Clinical Follow-up (PMCF) of the Safety and Efficacy of the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System When Used for Transhumeral Implantation in Amputee Patients
Last checked: Nov 19, 2026Latest source record: Jul 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Feb 19, 2025
Primary completion
Dec 2025
Study completion Mar 2026
Sponsor
- Lead sponsor
- IntegrumNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 31, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This non-interventional clinical investigation is initiated for the purpose of long-term Post-Market Clinical Follow-up (PMCF) and the follow-up time of patients is expected to span from 6 months to \>20 years in function. It will collect and evaluate clinical data on the safety and performance of the OPRA™ Implant System when used on transhumeral amputees and within the scope of the intended use.
Conditions
- Amputation of Upper Limb
Interventions
OPRA transhumeralDevice
Skeletal anchorage of amputation prostheses.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Implant Safety and EffectivnessTime frame: 2 years post implant surgery
Locations
6 sites in 5 countries. Site status is shown where the registry gives one.
The Alfred Hospital
Melbourne, Victoria, Australia · Not yet recruiting
Medical University of Vienna Clinical laboratory for bionic limb reconstruction Währinger Gürtel 18-20 1090 Vienna, AUSTRIA
Vienna, Austria · Recruiting
University Hospital Ghent, UX Ghent
Ghent, Belgium · Not yet recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.